Facebook
X
LinkedIn
ForwardPulse: Immune checkpoint inhibitor use in transplant
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
There is no specific guideline of when and where to use immune checkpoint inhibitors (ICI) in transplant patients. This presentation will discuss recommendation of ICI use in transplant patients based on published studies.
Target Audience
Pharmacist
Learning Objectives
Define immune checkpoint inhibitors (ICI)
Explain mechanism of action of ICI
Recognize risk of rejection after initiation of ICI
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide_24.pptx | 460.19 KB |
 PULSE_Vahora.pdf | 152.64 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
There is no specific guideline of when and where to use immune checkpoint inhibitors (ICI) in transplant patients. This presentation will discuss recommendation of ICI use in transplant patients based on published studies.
Ahmadbahi Vahorasarfarj, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.